Prevalence of HCV resistance‐associated substitutions among treatment‐failure patients receiving direct‐acting antiviral agents
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13270
Abstract: Direct‐acting antiviral (DAA) failure, which is mainly associated with the selection of resistance‐associated substitutions (RASs), is not rare in HCV treatment. RAS data collected from published literature and RAS prevalence were integrated using meta‐analysis. DAA‐failure‐associated… read more here.
Keywords: failure patients; treatment; daa failure; rass ... See more keywords